FI104076B1 - Menetelmä farmaseuttisesti vaikuttavien triatsolopyridatsiiniyhdisteiden valmistamiseksi - Google Patents

Menetelmä farmaseuttisesti vaikuttavien triatsolopyridatsiiniyhdisteiden valmistamiseksi

Info

Publication number
FI104076B1
FI104076B1 FI931190A FI931190A FI104076B1 FI 104076 B1 FI104076 B1 FI 104076B1 FI 931190 A FI931190 A FI 931190A FI 931190 A FI931190 A FI 931190A FI 104076 B1 FI104076 B1 FI 104076B1
Authority
FI
Finland
Prior art keywords
optionally substituted
stands
group
lower alkyl
alkyl group
Prior art date
Application number
FI931190A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI931190A0 (fi
FI104076B (fi
FI931190A (fi
Inventor
Akio Miyake
Yasuhiko Kawano
Yasuko Ashida
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI931190A0 publication Critical patent/FI931190A0/fi
Publication of FI931190A publication Critical patent/FI931190A/fi
Priority to FI982493A priority Critical patent/FI982493A0/fi
Application granted granted Critical
Publication of FI104076B1 publication Critical patent/FI104076B1/fi
Publication of FI104076B publication Critical patent/FI104076B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
FI931190A 1992-03-18 1993-03-17 Menetelmä farmaseuttisesti vaikuttavien triatsolopyridatsiiniyhdisteiden valmistamiseksi FI104076B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI982493A FI982493A0 (fi) 1992-03-18 1998-11-18 Triatsolopyridatsiiniyhdisteet ja niiden käyttö

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP6178092 1992-03-18
JP6178092 1992-03-18
JP21890492 1992-08-18
JP21890492 1992-08-18
JP1456093 1993-02-01
JP1456093 1993-02-01

Publications (4)

Publication Number Publication Date
FI931190A0 FI931190A0 (fi) 1993-03-17
FI931190A FI931190A (fi) 1993-09-19
FI104076B1 true FI104076B1 (fi) 1999-11-15
FI104076B FI104076B (fi) 1999-11-15

Family

ID=27280691

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931190A FI104076B (fi) 1992-03-18 1993-03-17 Menetelmä farmaseuttisesti vaikuttavien triatsolopyridatsiiniyhdisteiden valmistamiseksi

Country Status (22)

Country Link
US (1) US5389633A (hu)
EP (1) EP0562439B1 (hu)
CN (1) CN1040874C (hu)
AT (1) ATE181075T1 (hu)
AU (1) AU654430B2 (hu)
CA (1) CA2091874A1 (hu)
DE (1) DE69325199T2 (hu)
DK (1) DK0562439T3 (hu)
EE (1) EE9400357A (hu)
ES (1) ES2132147T3 (hu)
FI (1) FI104076B (hu)
GR (1) GR3030817T3 (hu)
HK (1) HK1009700A1 (hu)
HU (2) HU218791B (hu)
LT (1) LT3200B (hu)
LV (1) LV10456B (hu)
MY (1) MY108967A (hu)
NO (1) NO300774B1 (hu)
NZ (1) NZ247171A (hu)
PH (1) PH29998A (hu)
RU (1) RU2130458C1 (hu)
TW (1) TW255891B (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571821A (en) * 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5464853A (en) * 1993-05-20 1995-11-07 Immunopharmaceutics, Inc. N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) * 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5736509A (en) * 1990-12-14 1998-04-07 Texas Biotechnology Corporation Cyclic peptide surface feature mimics of endothelin
US5482939A (en) * 1992-03-18 1996-01-09 Takeda Chemical Industries, Ltd. Triazolopyridazine compounds, their production and use
DE69411616T2 (de) * 1993-04-12 1998-11-19 Takeda Chemical Industries Ltd Triazolopyridazin-Derivate, ihre Herstellung und Verwendung
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
TW304878B (hu) * 1993-09-21 1997-05-11 Takeda Pharm Industry Co Ltd
ATE201875T1 (de) * 1994-09-16 2001-06-15 Takeda Chemical Industries Ltd Triazolopyridazine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel
US5977117A (en) 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5804585A (en) * 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
CA2285264A1 (en) * 1997-04-25 1998-11-05 Michiyo Gyoten Condensed pyridazine derivatives, their production and use
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
US6432994B1 (en) 1997-04-28 2002-08-13 Texas Biotechnology Corporation Sulfonamides for treatment of endothelin-mediated disorders
WO1999044611A1 (en) * 1998-03-04 1999-09-10 Takeda Chemical Industries, Ltd. Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases
CA2346659A1 (en) 1998-10-06 2000-04-13 Michiyo Gyoten Condensed pyridazine compounds, their production and use
WO2000023450A1 (fr) 1998-10-21 2000-04-27 Takeda Chemical Industries, Ltd. Derives fusionnes de pyridazine, procede de preparation correspondant et utilisation de ces derives
WO2009097971A1 (de) * 2008-02-05 2009-08-13 Sanofi-Aventis Triazoliumsalze als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel
SG182297A1 (en) 2009-12-31 2012-08-30 Ct Nac Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
WO2012098387A1 (en) 2011-01-18 2012-07-26 Centro Nacional De Investigaciones Oncológicas (Cnio) 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
WO2013005057A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) New compounds
WO2013004984A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncologicas (Cnio) Tricyclic compounds for use as kinase inhibitors
WO2013005041A1 (en) 2011-07-07 2013-01-10 Centro Nacional De Investigaciones Oncológicas (Cnio) Tricyclic heterocyclic compounds as kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915968A (en) 1973-09-21 1975-10-28 Lepetit Spa Triazolopyridazines
US4136182A (en) 1976-05-26 1979-01-23 The Dow Chemical Company Triazolopyridazines used to alleviate bronchial spasms
PH27291A (en) * 1989-01-31 1993-05-04 Takeda Chemical Industries Ltd Imidazolpyrimidazines their production and use
EP0440119A1 (en) * 1990-01-31 1991-08-07 Takeda Chemical Industries, Ltd. Imidazopyridazine compounds, their production and use
ATE117690T1 (de) * 1990-03-01 1995-02-15 Takeda Chemical Industries Ltd Imidazopyridazine, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
US5389633A (en) 1995-02-14
LV10456B (en) 1995-10-20
CN1077958A (zh) 1993-11-03
FI931190A0 (fi) 1993-03-17
NZ247171A (en) 1994-09-27
CA2091874A1 (en) 1993-09-19
TW255891B (hu) 1995-09-01
NO930974L (no) 1993-09-20
LV10456A (lv) 1995-02-20
DE69325199D1 (de) 1999-07-15
AU3526993A (en) 1993-09-23
NO300774B1 (no) 1997-07-21
DK0562439T3 (da) 1999-11-15
HU211326A9 (en) 1995-11-28
EP0562439A1 (en) 1993-09-29
LTIP390A (lt) 1994-08-25
FI104076B (fi) 1999-11-15
PH29998A (en) 1996-10-29
HK1009700A1 (en) 1999-06-04
CN1040874C (zh) 1998-11-25
DE69325199T2 (de) 1999-12-16
AU654430B2 (en) 1994-11-03
HU9300759D0 (en) 1993-06-28
EE9400357A (et) 1996-04-15
FI931190A (fi) 1993-09-19
HU218791B (hu) 2000-12-28
RU2130458C1 (ru) 1999-05-20
LT3200B (en) 1995-03-27
ATE181075T1 (de) 1999-06-15
ES2132147T3 (es) 1999-08-16
GR3030817T3 (en) 1999-11-30
HUT65935A (en) 1994-08-29
MY108967A (en) 1996-11-30
NO930974D0 (no) 1993-03-17
EP0562439B1 (en) 1999-06-09

Similar Documents

Publication Publication Date Title
FI104076B1 (fi) Menetelmä farmaseuttisesti vaikuttavien triatsolopyridatsiiniyhdisteiden valmistamiseksi
JPS56167643A (en) Mannich base hydroxamic acid precursor drug for improving transmission of non-steroid antiinflammatory
AU652981B2 (en) Condensed benzoxa ring compound, production thereof, and pharmaceutical composition containing the same
SG50546A1 (en) Quinoline or quinazoline derivatives their production and use
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
HUT50160A (en) Process for production of derivatives of tiophene and medical compositions containing them as active substance
DE69322673D1 (de) Imidazopyridazine als Antiasthmatika
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
ATE61362T1 (de) Ein thiophenderivat und verfahren zu dessen herstellung.
SE7905051L (sv) Nya sulfonamider
JPS5515457A (en) Dithiocarbamic acid derivative
GB1346016A (en) Triazolothienodiszepine compounds methods for their preparation and pharmaceutical compositions containing tthem
JPS55143990A (en) Preparation of novel diamine derivative, and thienodiazepin-2-one derivative containing the same